These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 5822799)
61. Comparison of proteomes in various human plasma preparations by two-dimensional gel electrophoresis. Kim HJ; Kim MR; So EJ; Kim CW J Biochem Biophys Methods; 2007 Jun; 70(4):619-25. PubMed ID: 17368557 [TBL] [Abstract][Full Text] [Related]
64. Immunodepletion of albumin for two-dimensional gel detection of new mouse acute-phase protein and other plasma proteins. Duan X; Yarmush D; Berthiaume F; Jayaraman A; Yarmush ML Proteomics; 2005 Oct; 5(15):3991-4000. PubMed ID: 16130172 [TBL] [Abstract][Full Text] [Related]
65. [Spectrofluorometric analysis of protein fractions of blood serum of health donors and patients with kidney diseases]. Parkhomenko TV; Klytsenko OA; Shavlovskiĭ MM; Poletaev AI; Kuznetsova IM; Turoverov KK Tsitologiia; 1998; 40(8-9):786-91. PubMed ID: 9821250 [TBL] [Abstract][Full Text] [Related]
66. [Ultramicro-ELISA for measuring tetanus antitoxin in human serum]. Fajardo EM; Fernández JL; Solís RL; Portuondo B; Heredia L; Noroña M; Urquiza H; Amat M Bol Oficina Sanit Panam; 1995 Aug; 119(2):113-20. PubMed ID: 7546296 [TBL] [Abstract][Full Text] [Related]
68. Plasmapheresis and cytapheresis. Nosé Y; Gurland HJ; Klein HG; Malchesky PS; Ota K Trans Am Soc Artif Intern Organs; 1982; 28():631-8. PubMed ID: 7164316 [No Abstract] [Full Text] [Related]
69. Application of LoGrippo's method for the pre-treatment of human plasma before fractionation. Melin M; Goolsby CM; Jansky JW Vox Sang; 1969 Jul; 17(1):61-2. PubMed ID: 5798764 [No Abstract] [Full Text] [Related]
70. Membranes in artificial organs: a state-of-the-problem discussion. Sparks RE; Dorson WJ; Richardson PD; Colton CK; Malchesky P Trans Am Soc Artif Intern Organs; 1983; 29():760-3. PubMed ID: 6673322 [No Abstract] [Full Text] [Related]
71. Plasmapheresis in patients with disseminated cancer: clinical results and correlation with changes in serum protein. The concept of "nonspecific blocking factors". Israel L; Edelstein R; Mannoni P; Radot E; Greenspan EM Cancer; 1977 Dec; 40(6):3146-54. PubMed ID: 589571 [No Abstract] [Full Text] [Related]
72. [The effect of modified nano-diamonds of detonation synthesis on the protein fractions of human blood]. Botvich IuA; Olkhovskiĭ IA; Baron II; Puzyr' AP; Baron AV; Bondar' VS Klin Lab Diagn; 2013 Nov; (11):35-9. PubMed ID: 24640108 [TBL] [Abstract][Full Text] [Related]
73. [Testing and transportation of protein solutions in the production of blood preparations]. Skobelev LI; From AA; Mikhaĭlov GV Probl Gematol Pereliv Krovi; 1971 Oct; 16(10):61-3. PubMed ID: 5125901 [No Abstract] [Full Text] [Related]
74. Plasma fractionation in England and Wales. Vallet L Vox Sang; 1972; 23(1):58-60. PubMed ID: 4628157 [No Abstract] [Full Text] [Related]
75. [Plasmapheresis as a method for obtaining blood derivatives in traumatology]. Lautner A Wien Med Wochenschr; 1968 May; 118(20):469-71. PubMed ID: 5702498 [No Abstract] [Full Text] [Related]
76. New trends in plasma fractionation. Steinbuch M Haematologia (Budap); 1983; 16(1-4):39-51. PubMed ID: 6207083 [No Abstract] [Full Text] [Related]
77. [Plasmapheresis for the isolation of coagulating plasma fractions]. Matthes M Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):327-33. PubMed ID: 4195277 [No Abstract] [Full Text] [Related]
78. [Plasmapheresis as a method of production of blood fractions]. Lautner A Bibl Haematol; 1969; 32():212-6. PubMed ID: 5822799 [No Abstract] [Full Text] [Related]